AI Guest Author: A New Report on Better External Control Arms via N-Power Medicine Series B

 

I saw a headline that N-Power Medicine, which promises new ways to do oncology trials, had raised $32M by large investors, including LabCorp.   Their game is a next-generation approach to "external control arms," or ECAs, for clinical trials.   I've run across ECAs at regular intervals, and I asked Chat GPT to provide me an update, in the form of a report.

Happy to share it - find it here:

https://drive.google.com/file/d/178h4Q4oenGRBVp-z-9lcH1M3FVnxndSx/view?usp=sharing